Stock listing

KRYS Stock Price, News, Filings & Events — Krystal Biotech, Inc.

Selected listing: KRYS · BOATS · USD · US

This page tracks Krystal Biotech, Inc.'s KRYS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KRYS:BOATS. KRYS:BOATS is the stock-level entry point for investors researching Krystal Biotech, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Krystal Biotech, Inc. (ticker: KRYS) is a public company based in the United States with a market capitalization of approximately $10.78 billion. The company focuses on developing innovative gene therapies for various dermatological conditions. Krystal Biotech aims to address unmet medical needs through its proprietary technology platform.

KRYS:BOATSUSDUSUpdated July 21, 2026
Krystal Biotech, Inc. logo
Ticker
KRYS:BOATS
Asset type
Stock
Market cap
$10.78B
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Krystal Biotech, Inc. KRYS:BOATS stock context

This page tracks Krystal Biotech, Inc.'s KRYS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KRYS:BOATS. KRYS:BOATS is the stock-level entry point for investors researching Krystal Biotech, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Krystal Biotech, Inc. (ticker: KRYS) is a public company based in the United States with a market capitalization of approximately $10.78 billion. The company focuses on developing innovative gene therapies for various dermatological conditions. Krystal Biotech aims to address unmet medical needs through its proprietary technology platform.

Research Krystal Biotech, Inc.

Alternate listings